Table 5.
Characteristics of survivors and non-survivors in the ICU
|
Survivors (n=38) |
Non-survivors (n=39) |
P |
|
|---|---|---|---|
|
Sex (male) |
22 (58) |
23 (59) |
.814 |
|
Age (years) |
56 (35, 69) |
63 (54, 73) |
.029 |
|
Medical patients |
14 (37) |
15 (38) |
1.0 |
|
APACHE II score |
16 (12, 21) |
19 (16, 24) |
.008 |
|
SOFA score |
6 (4, 8) |
8 (6, 11) |
.004 |
|
Charlson score |
1 (0, 2) |
2 (1, 4) |
.003 |
|
Total ICU duration (days) |
29 (18, 38) |
16 (11, 32) |
.023 |
|
MV total duration (days) |
22 (14, 30) |
16 (11, 38) |
.318 |
|
Sedation total duration (days) |
8 (4, 17) |
10 (5, 16) |
.547 |
|
Colistin-resistant A. baumannii infection |
3 (8) |
17 (44) |
.001 |
|
Patients with BSI |
10 |
23 |
.006 |
|
Patients with VAP |
26 (68) |
16 (41) |
.022 |
Data are presented as median (25 %, 75 % quartiles) or n (%); ICU, intensive care unit; APACHE, acute physiology and chronic health evaluation; SOFA, sequential organ failure assessment; MV, mechanical ventilation; P, comparison between the two groups. Results by univariate analysis.